UK 
EN 
When considering manuscripts, the Editorial team is guided by international standards, recommendations, and resources on all aspects of publication ethics, in accordance with the requirements of the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), and the International Committee of Medical Journal Editors (ICMJE), as well as by current regulatory documents on standardization in the field of publishing in Ukraine, which provide guidance on best practices in the conduct and reporting of medical research. In the event of identified violations of publication ethics in published material, please contact the Editorial Office of the journal Medicni Perspektivi at:
In its publishing activities, the Editorial team adheres to high standards, consistent with those of its publisher, Dnipro State Medical University, and seeks to ensure that the research published in the journal Medicni Perspektivi complies with the following principles:
- high quality of research;
- transparency and openness in communication;
- honesty and integrity in all aspects of research;
- respect for all research participants.
The Editorial team of the journal Medicni Perspektivi maintains editorial independence and seeks to prevent violations of these principles arising from corporate, financial, or political influence, as well as from conflicts of interest or any other factors. The journal does not discriminate against authors, editors, or reviewers on the basis of personal characteristics, nationality, religion, academic rank or position, or social status. Manuscripts submitted for publication are initially assessed by the Editorial team, which may also consult with relevant editors from the Editorial board, which include leading scientists from Ukraine and other countries (the United Kingdom, Germany, Israel, France, Lithuania, Poland, Sweden, etc.). If a manuscript falls within the scope of the journal and meets its principles, it is sent for external independent peer review by at least two reviewers. Peer review is essential for maintaining the standards of the journal Medicni Perspektivi. Editors and reviewers are encouraged to follow the COPE Ethical Guidelines for Peer Reviewers. Reviewers’ reports are used by editors to make decisions on whether to recommend publication in the journal. Editors may also request additional reviews or further information from the authors. The Editor-in-Chief and the Editorial team make the final decision on acceptance or rejection of a manuscript based solely on the following criteria:
- relevance and contribution to contemporary medical science;
- originality;
- clarity of presentation;
- consistency between the title, objectives, results, and conclusions;
- alignment with the journal’s scope;
- adequate revision of issues identified during peer review;
- compliance with the journal’s Guidelines for Authors.
Authors who disagree with the rejection of their manuscript may submit an appeal. The appeal must contain substantial arguments and convincing evidence addressing the reviewers’ comments. Resubmission of a manuscript for further consideration does not guarantee its publication in the journal Medicni Perspektivi. The manuscript may be re-evaluated by the original or new reviewers, as well as by the editors of the journal. Appeals and complaints may be sent to the Editorial Office by email:
The relationship between the Editorial Office and the author is governed by an authorship agreement concerning the use of the results and materials of the article. In turn, the author(s) are responsible for the accuracy of the submitted materials and for all aspects of the work related to the integrity of the study, and must ensure that the manuscript has not been published elsewhere. Prior to publication, the article proofs are sent to the author for final approval.
The editors of the journal Medicni Perspektivi consider that authorship should be based on substantial contributions to the conception and design of the study, data collection, analysis and interpretation of data, drafting of the manuscript, critical evaluation of the work in the context of current advances and relevant issues in medicine, approval of the final version of the article to be published, and adherence to standards of responsible research conduct. Publications based on fabricated data may harm society and health research. The order of authorship should be agreed upon prior to manuscript preparation. Upon submission of a revised manuscript, the order of authorship may not be changed without valid justification. Any changes to the order of authorship require the written consent of all authors. Editors recommend that authors list individuals who do not meet the criteria for authorship in the Acknowledgments section to recognize their contribution to the research or manuscript preparation. The corresponding author serves as the primary contact for all editorial inquiries, including after publication. Editors require the corresponding author to confirm in writing that they are authorized to act on behalf of all co-authors in all matters related to the manuscript. The corresponding author is responsible for informing co-authors about the progress of the manuscript during submission, peer review, and publication. Authorship disputes are resolved in accordance with the recommendations of COPE, WAME, and ICMJE. The editors of the journal strive to align with established and emerging industry standards to enhance transparency of authorship (e.g., the use of ORCID identifiers).
In order to ensure the quality standards of a scientific journal, the Editorial team implements a number of measures to prevent plagiarism, duplication of submitted materials, and self-plagiarism in published content. Plagiarism is defined as the use of others’ ideas, words, data, or other materials without proper attribution to the original source. Duplicate publication, or “self-plagiarism,” occurs when a work or substantial parts of a work are published more than once by the same author without appropriate citation or justification. This may occur in the same or different languages. However, the posting of a preprint on an author’s personal website, in an institutional repository, or in a preprint archive is not considered duplicate publication. To detect duplication of submitted materials in other publications and potential plagiarism, all manuscripts submitted to the journal are screened using the licensed system StrikePlagiarism.com. Confirmed cases of duplicate publication, plagiarism, or data falsification constitute grounds for rejection of the manuscript, in accordance with COPE recommendations (https://doi.org/10.24318/cope.2019.1.4). The Editorial team of the journal expects readers, reviewers, and editors to report any suspected cases of plagiarism by contacting the Editorial Office at:
The Editorial team condemns citation manipulation and considers excessive self-citation unacceptable, except where such references add substantial value to the scientific content of the manuscript.
Advertising is not accepted in the journal.
On the Use of Generative AI (GenAI) and Related Technologies
In cases where authors use generative artificial intelligence (GenAI) or related technologies in the preparation of a manuscript, such tools must be used solely to enhance readability and improve the linguistic quality of the text. Their use must remain under the author’s control. Authors bear full responsibility for the content, accuracy, and originality of the work.
Authors are required to clearly disclose in their manuscripts any use of generative AI or related technologies. Such a statement (including the name of the AI tool, its version, and the manufacturer) will be published alongside the article. This disclosure promotes transparency and trust among authors, reviewers, editors, readers, and co-authors, and confirms compliance with the terms of use of the respective tool.
The use of AI in a manuscript may be declared using the free Generative AI Delegation Taxonomy (GAIDeT).
Authors must not list AI or AI-based tools as an author or co-author, nor cite AI as an author.
The Editorial team does not permit the use of AI or AI-based tools to create, edit, or modify images in submitted manuscripts. Such images may be non-representative, distort the meaning of the presented data, provide misleading information, and compromise scientific integrity. Exceptions are permitted where the use of generative AI or AI-based tools constitutes an integral part of the research design or methodology (e.g., in biomedical imaging for the acquisition or interpretation of primary data). In such cases, the use of AI must be described in detail in the “Materials and Methods” section. This description should specify how generative AI or AI-based tools were used in the creation or modification of images, as well as the name of the model or tool, version number(s), extensions (if applicable), and the manufacturer.
Failure to comply with these requirements may result in rejection of the manuscript during peer review or retraction of a published article.
Research involving humans or animals must be approved by the relevant ethics committees and must comply with international ethical and legal standards for research. When reporting clinical experiments involving patients, their right to confidentiality and privacy must not be violated without their consent. If an article contains any information that could identify a patient (e.g., photographs, names, initials, medical record numbers in images or text, etc.), the patient’s informed written consent for publication must be obtained prior to manuscript submission to the Editorial Office. The article must clearly state compliance with the principles of bioethics set out in the WMA Declaration of Helsinki – “Ethical Principles for Medical Research Involving Human Subjects”, the UNESCO Universal Declaration on Bioethics and Human Rights, and the Order of the Ministry of Health of Ukraine “On Approval of the Procedure for Clinical Trials of Medicinal Products and Expert Evaluation of Clinical Trial Materials and Model Regulations on Ethics Committees” No. 690 of 23 September 2009. When reporting animal experiments, it should be stated whether the housing and use of laboratory animals complied with the requirements set out in the Law of Ukraine “On Protection of Animals from Cruel Treatment” No. 3447-IV of 21 February 2006, the Order of the Ministry of Education and Science of Ukraine “On Approval of the Procedure for Conducting Experiments on Animals by Scientific Institutions” No. 249 of 1 March 2012, the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS No. 123, 1986), and Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes, as amended, or equivalent regulations of other countries.
When submitting a manuscript, authors are required to disclose to the Editorial team any potential conflicts of interest that may affect the objectivity or integrity of the publication, or to explicitly state their absence (for further details, see the section “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”, ICMJE, COPE). A conflict of interest is defined as any situation that could be perceived as having an undue influence on the presentation, peer review, or publication of a scientific work. Conflicts of interest may be financial, non-financial, professional, contractual, or personal in nature. The Editorial team expects that anyone who suspects an undisclosed conflict of interest in relation to a manuscript published or under consideration by the journal Medicni Perspektivi will notify the Editorial Office by email.
The Editors of the journal Medicni Perspektivi consider corrections, retractions, and expressions of concern in accordance with the COPE Retraction Guidelines. The Editorial team may make minor corrections to articles in which typographical errors were introduced during typesetting or editing. More substantial corrections are made only in accordance with COPE recommendations. If an error is identified by the author, a correction will be published in the journal Medicni Perspektivi. Retraction of a published article is considered in the following cases:
- the article contains serious flaws and there is clear evidence that the findings are unreliable, either as a result of a major error (e.g., miscalculation or experimental error) or as a result of misconduct (e.g., data fabrication or image manipulation), making the conclusions invalid;
- plagiarism;
- the results have been previously published elsewhere without proper citation, permission for republication, or justification (duplicate publication);
- the article contains materials or data used without authorization;
- copyright has been violated or there are other serious legal issues (e.g., defamation or breach of confidentiality);
- unethical research practices have been proven;
- the article was published on the basis of a manipulated peer-review process;
- the author(s) failed to disclose a relevant conflict of interest that could affect the interpretation of the research or the decisions of editors and reviewers.
Retraction of a published article is carried out after careful investigation and approval by the Editor-in-Chief. The retracted article is marked as retracted, and a retraction notice is published in the journal Medicni Perspektivi issue as well as in all online versions of the journal. The retraction notice is made freely accessible as soon as possible in order to minimize potential harm, and includes the reason for retraction and full bibliographic metadata of the article.
The Editors of the journal Medicni Perspektivi consider retraction of an article inappropriate in the following cases:
- the author discloses a conflict of interest to the Editorial Office after publication, but, in our assessment, the conflict of interest did not affect the interpretation, recommendations, or conclusions of the article;
- authorship is disputed, but there is no reason to question the reliability of the results;
- correction of an error in the article is sufficient to resolve the issue, while the main findings remain reliable and the conclusions valid;
- there is no convincing evidence supporting a retraction.
The Editors are committed to the principles of transparency and best practice in scientific publishing as recommended by COPE. The Editorial team of the journal Medicni Perspektivi follows an open access policy for published content, supporting the free dissemination of scientific information and the exchange of knowledge for global societal progress. By submitting a manuscript to the journal Medicni Perspektivi, authors agree that the rights to use and protect the manuscript are transferred to the Editorial team (including copyright-protected materials such as photographs, drawings, diagrams, tables, etc.) for reproduction in the journal, online distribution, translation into other languages, and dissemination of journal copies containing the author’s article, without time or geographical restrictions, both in Ukraine and worldwide. These and other mutual obligations of the author(s) (and all co-authors individually) and the Editorial team are governed by a written copyright transfer agreement in a prescribed form, a sample of which is provided in the Instructions for Authors. The agreement is completed by the author and submitted to the Editorial Office together with the manuscript.